Data presented at the European Hematology Association Congress show EpiCept’s Histamine H2 agonist Ceplene to improve leukemia free survival (LFS) in acute myeloid leukemia (AML) patients.
Filed under: gpcr | Tagged: agonist, Ceplene, EpiCept, EpiLeukin, gpcr, Histamine H2, Maxamine |
Δ
Leave a comment